
Opinions
Michael Smedley
NUCRYST Pharmaceuticals Corp.
NCS-T
PAST TOP PICK
Aug 03, 2007
$2.960
Stock price when the opinion was issued
biotechnology
pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.